Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.

Kimura M, Taniguchi H, Kondoh Y, Kimura T, Kataoka K, Nishiyama O, Aso H, Sakamoto K, Hasegawa Y.

Respiration. 2013;85(6):456-63. doi: 10.1159/000345221. Epub 2012 Dec 19.

PMID:
23257350
2.

Pulmonary hypertension in chronic lung diseases.

Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs S, Martinez FJ, Semigran MJ, Simonneau G, Wells AU, Vachiéry JL.

J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16. doi: 10.1016/j.jacc.2013.10.036. Review.

3.

Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.

Pitsiou G, Papakosta D, Bouros D.

Respiration. 2011;82(3):294-304. doi: 10.1159/000327918. Epub 2011 Jun 15. Review.

PMID:
21677422
4.

Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis.

Lefèvre G, Dauchet L, Hachulla E, Montani D, Sobanski V, Lambert M, Hatron PY, Humbert M, Launay D.

Arthritis Rheum. 2013 Sep;65(9):2412-23. doi: 10.1002/art.38029. Review.

5.

Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.

Corte TJ, Wort SJ, Wells AU.

Sarcoidosis Vasc Diffuse Lung Dis. 2009 Jul;26(1):7-19. Review.

PMID:
19960783
6.

Staging of idiopathic pulmonary fibrosis: past, present and future.

Kolb M, Collard HR.

Eur Respir Rev. 2014 Jun;23(132):220-4. doi: 10.1183/09059180.00002114. Review.

7.

Pulmonary hypertension in the course of diffuse parenchymal lung diseases - state of art and future considerations.

Szturmowicz M, Kacprzak A, Błasińska-Przerwa K, Kuś J.

Pneumonol Alergol Pol. 2015;83(4):312-23. doi: 10.5603/PiAP.2015.0051. Review.

8.

Pulmonary hypertension in idiopathic pulmonary fibrosis.

Patel NM, Lederer DJ, Borczuk AC, Kawut SM.

Chest. 2007 Sep;132(3):998-1006. Review.

PMID:
17873194
9.

Prognostic factors in idiopathic pulmonary fibrosis.

Tzilas V, Koti A, Papandrinopoulou D, Tsoukalas G.

Am J Med Sci. 2009 Dec;338(6):481-5. doi: 10.1097/MAJ.0b013e3181ad5984. Review.

PMID:
19826245
10.

Pulmonary hypertension and idiopathic pulmonary fibrosis: a dastardly duo.

Smith JS, Gorbett D, Mueller J, Perez R, Daniels CJ.

Am J Med Sci. 2013 Sep;346(3):221-5. doi: 10.1097/MAJ.0b013e31827871dc. Review.

PMID:
23313949
11.

Predicting prognosis in idiopathic pulmonary fibrosis.

Barlo NP, van Moorsel CH, van den Bosch JM, Grutters JC.

Sarcoidosis Vasc Diffuse Lung Dis. 2010 Jul;27(2):85-95. Review.

PMID:
21319590
12.

Pulmonary hypertension associated with chronic obstructive lung disease and idiopathic pulmonary fibrosis.

Adir Y, Harari S.

Curr Opin Pulm Med. 2014 Sep;20(5):414-20. doi: 10.1097/MCP.0000000000000084. Review.

PMID:
25046428
13.

[Physiological functional tests to evaluate pulmonary arterial hypertension].

Chaouat A, Canuet M, Kraemer JP, Enache I, Ducoloné A, Kessler R, Weitzenblum E.

Rev Mal Respir. 2005 Dec;22(6 Pt 1):991-7. Review. French.

PMID:
16222224
14.

Usefulness of a disease severity staging classification system for IPF in Japan: 20 years of experience from empirical evidence to randomized control trial enrollment.

Homma S, Sugino K, Sakamoto S.

Respir Investig. 2015 Jan;53(1):7-12. doi: 10.1016/j.resinv.2014.08.003. Epub 2014 Oct 16. Review.

PMID:
25542598
15.

Palliative and end-of-life care for patients with idiopathic pulmonary fibrosis: challenges and dilemmas.

Lewis D, Scullion J.

Int J Palliat Nurs. 2012 Jul;18(7):331-7. Review.

PMID:
22885965
16.

Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?

Nathan SD, King CS.

Drug Des Devel Ther. 2014 Jul 2;8:875-85. doi: 10.2147/DDDT.S64907. eCollection 2014. Review.

17.

Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium.

Nathan SD, Shlobin OA, Weir N, Ahmad S, Kaldjob JM, Battle E, Sheridan MJ, du Bois RM.

Chest. 2011 Jul;140(1):221-229. doi: 10.1378/chest.10-2572. Review.

PMID:
21729893
18.

[Idiopathic pulmonary fibrosis: new insights].

Kraan JW, van den Blink B, van den Toorn LM, Bresser P, van Beek FT, Grutters JC, Wijsenbeek MS.

Ned Tijdschr Geneeskd. 2015;159:A8148. Review. Dutch.

PMID:
25654681
19.

Pulmonary hypertension: the importance of correctly diagnosing the cause.

Mehta S, Vachiéry JL.

Eur Respir Rev. 2016 Dec;25(142):372-380. doi: 10.1183/16000617.0104-2016. Review.

Supplemental Content

Support Center